resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on hamilton Depression Rating Scale (HDRS) total score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“HDRS scores and its changes, ESRS score, and frequency of other complications were not significantly different between resveratrol and placebo groups.”
Quoted verbatim from Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg/d
- Population
- Patients with stable schizophrenia on a stable dose of risperidone in both arms; resveratrol versus matched placebo
Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial.2020PMID:33372679Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Hamilton Depression Rating Scale (HDRS) total score
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PCZSDWTGCX5GGGCZZJ3SRF